On Monday shares of Apricus Biosciences, Inc. (NASDAQ:APRI) closed at $1.94. Company’s sales growth for last 5 years was -16.10%. Apricus Biosciences, Inc. (NASDAQ:APRI) reported a Q4 net loss of $17.3 million, or $0.40 per share, compared with a net loss of $1.3 million, or $0.04 per share for Q4 2013. The company noted the widening in the quarterly net loss was primarily due to the in-licensing of fispemifene, a selective estrogen receptor modulator.
Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) in last trading activity moved down -0.34% to close at $11.75. Company weekly performance is -2.33% while its quarterly performance stands at 14.97%. Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) is -6.00% away from its 52 week high. Advanced Cell Diagnostics, Inc. (ACD) a company that provides a sensitive and specific RNA hybridization technology, recently announced that Merrimack Pharmaceutical Inc. (NASDAQ:MACK) is utilizing their leading technology to choose participants for a new Phase 2 clinical study to test the efficacy of the company’s drug candidate MM-121. ACD’s RNA scope technology will be used to select patients that have heregulin positive, advanced or metastatic non-small cell lung cancer (NSCLC).
On last trading day Amkor Technology, Inc. (NASDAQ:AMKR) increased 1.85% to close at $9.35. Its volatility for the week is 3.24% while volatility for the month is 3.62%. AMKR’s sales growth for past 5 years was 7.50% and its EPS growth for past 5 years was -3.90%. Amkor Technology, Inc. (NASDAQ:AMKR) monthly performance is 4.82%. Amkor Technology, Inc. (NASDAQ:AMKR) announced that it will participate in the following investor conference: Sidoti & Company’s 19th Annual Small-Cap Equity Conference on Tuesday, March 17, 2015. Amkor’s presentation will occur at 11:20 am Eastern Time at the Grand Hyatt Hotel in New York, NY.
On Monday shares of JA Solar Holdings Co., Ltd. (NASDAQ:JASO) closed at $8.89. Company’s sales growth for last 5 years was 5.60% and EPS growth for next 5 years is recorded as 22.00%. JA Solar Holdings Co., Ltd. (NASDAQ:JASO) announced that it will supply 35.1 MW of modules to the second phase of a Guatemala solar farm. The signing of the contract for phase II of the project for another 35.1MW of modules came after JA’s successful delivery of 59.7MW to the first phase in 2014.
Chevron Corporation (NYSE:CVX) in last trading activity increased 1.49% to close at $103.13. Company weekly performance is -0.79% while its quarterly performance stands at -0.73%. Chevron Corporation (NYSE:CVX) is -21.54% away from its 52 week high. Chevron Corporation (NYSE:CVX) is planning to increase its asset sales by 50 percent to $15 billion and curtail new investment for the next two years after plunging oil prices squeezed cash flow for the second-biggest U.S. energy producer. Chevron’s divestment of oil and natural gas fields and other exploration and production assets will continue through 2017, chairman and chief executive officer, John Watson said.